[Neurocysticercosis].
Neurocysticercosis is a leading cause of acquired epilepsy worldwide and endemic in underdeveloped and developing regions. As a result of increased migration and traveling, cases of neurocysticercosis reach Europe more frequently. Neurological symptoms are multifarious and often nonspecific, so that neurocysticercosis poses a diagnostic challenge. We report a case of a patient in whom the diagnosis of neurocysticercosis was achieved quickly via the patient's history, neuroimaging and serology.
Klinik und Poliklinik für Neurologie, Uniklinik Köln.
C
C
Tscherpel
Neuroradiologie, Krankenhaus Nordwest, Frankfurt am Main.
A
A
Gottschalk
Neurologie, Krankenhaus Nordwest, Frankfurt am Main.
U
U
Meyding-Lamadé
Klinik und Poliklinik für Neurologie, Uniklinik Köln.
G R
GR
Fink
Neurologie, Heilig Geist-Krankenhaus Köln.
L
L
Burghaus
D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D020019:Neurocysticercosis / Q000175:diagnosis* / Q000469:parasitology / Q000523:psychology; D059906:Neuroimaging; D012640:Seizures / Q000188:drug therapy / Q000209:etiology; D041201:Taenia solium; D016896:Treatment Outcome
D000871:Anthelmintics; D015766:Albendazole